Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Saunders

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|February 19, 1998
Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's DiseaseR Mayeux, A M Saunders, S Shea, et al.
Annals of Neurology|June 1, 1996
Alzheimer's disease and apolipoprotein E-4 allele in an Amish populationM A Pericak-Vance, C C Johnson, J B Rimmler, et al.
Biochimica Et Biophysica Acta|July 19, 2000
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selectionA M Saunders, M K Trowers, R A Shimkets, et al.
Anesthesiology|July 26, 2000
Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patientsS T Chew, M F Newman, W D White, et al.
Neurobiology of Aging|April 30, 1998
Cis-acting human ApoE tissue expression element is associated with human pattern of intraneuronal ApoE in transgenic miceA D Roses, J Gilbert, P T Xu, et al.
Lancet (London, England)|September 18, 1993
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseasesA M Saunders, K Schmader, J C Breitner, et al.
Current Alzheimer Research|May 20, 2011
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studiesC Harrington, S Sawchak, C Chiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1993
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer diseaseD E Schmechel, A M Saunders, W J Strittmatter, et al.
Arzneimittel-Forschung|March 1, 1995
Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's diseaseA D Roses, A M Saunders, E H Corder, et al.
Neuromuscular Disorders : NMD|October 10, 2013
Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptomsF L Mastaglia, A Rojana-udomsart, I James, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|February 19, 1998
Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's DiseaseR Mayeux, A M Saunders, S Shea, et al.
Annals of Neurology|June 1, 1996
Alzheimer's disease and apolipoprotein E-4 allele in an Amish populationM A Pericak-Vance, C C Johnson, J B Rimmler, et al.
Biochimica Et Biophysica Acta|July 19, 2000
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selectionA M Saunders, M K Trowers, R A Shimkets, et al.
Anesthesiology|July 26, 2000
Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patientsS T Chew, M F Newman, W D White, et al.
Neurobiology of Aging|April 30, 1998
Cis-acting human ApoE tissue expression element is associated with human pattern of intraneuronal ApoE in transgenic miceA D Roses, J Gilbert, P T Xu, et al.
Lancet (London, England)|September 18, 1993
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseasesA M Saunders, K Schmader, J C Breitner, et al.
Current Alzheimer Research|May 20, 2011
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studiesC Harrington, S Sawchak, C Chiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1993
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer diseaseD E Schmechel, A M Saunders, W J Strittmatter, et al.
Arzneimittel-Forschung|March 1, 1995
Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's diseaseA D Roses, A M Saunders, E H Corder, et al.
Neuromuscular Disorders : NMD|October 10, 2013
Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptomsF L Mastaglia, A Rojana-udomsart, I James, et al.
Pageof 16